The currently available methods for quantification of alpha-synuclein, p-alpha-synuclein, or other products in brain-derived EVs in the blood are not optimal for distinguishing PD from other movement disorders such as the essential tremor, neurodegeneration with brain iron accumulation, dystonic tremor, or multiple system atrophy. The gene discussed is SNCA; the disease is multiple system atrophy.